Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE

Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity.

The trailing-twelve-month return on equity at Shire plc (NASDAQ: SHPG) is 50.50%. Shire's PEG ratio is 1.01.

The trailing-twelve-month return on equity at GlaxoSmithKline plc (NYSE: GSK) is 50.00%. GlaxoSmithKline's EPS for the same period is $1.69.

The trailing-twelve-month return on equity at AbbVie Inc. (NYSE: ABBV) is 43.50%. AbbVie's revenue for the same period is $19.96 billion.

The trailing-twelve-month return on equity at Merck & Co. Inc. (NYSE: MRK) is 24.80%. Merck's EPS growth forecast for the next year is 12.59%.